Stocks Under $10: VimpelCom

Richard Suttmeier  |

VimpelCom (VIP) – ($9.91) has a Strong Buy rating according to ValuEngine with fair value at $12.89, which makes the stock 23.1% undervalued. The stock has a one-year price target at $11.56. ValuEngine Profile – “VimpelCom Ltd. is one of the world's largest integrated telecommunications services operators. It offers a wide range of wireless, fixed, and broadband services in Russia, Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Armenia, Georgia, Kyrgyzstan, Vietnam, Cambodia, Laos, Algeria, Bangladesh, Pakistan, Burundi, Zimbabwe, Central African Republic, Italy and Canada. VimpelCom provides services under the Beeline, Kyivstar, djuice, Wind, Infostrada Mobilink, Leo, Banglalink, Telecel, and Djezzy brands. VimpelCom Ltd. is headquartered in Amsterdam, the Netherlands.”

Analysis – The daily chart for VIP shows oversold momentum with the stock below its 21-day, 50-day and 200-day simple moving averages at $10.49, $11.18 and $11.32. My quarterly value level is $7.48 with a monthly pivot at $10.05 and annual risky level at $16.31.

Courtesy of Thomson / Reuters



Courtesy of Thomson / Reuters

 

Ticker

Company Name

Mkt Price

Fair Value

One-Year Price Target

Last 12-Mon Retn (%)

5-Yr Avg Retn (%)

P/E Ratio

VIP

VIMPELCOM

9.91

12.89

11.56

24.97

-16.67

7.00

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
VIP UEX Corporation n/a n/a n/a n/a
RMTI Rockwell Medical Inc. 4.19 0.00 0.00 0 Trade

Comments

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…